Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Item
http://www.wikidata.org/entity/Q38449565
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Rectal neuroendocrine tumor with uncommon metastatic spread: A case report and review of literature.Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4.Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.Chemotherapy in NETs: When and how.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.Update in the Therapy of Advanced Neuroendocrine Tumors.
P2860

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Item
http://www.wikidata.org/entity/Q38449565
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
@en
type
label
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
@en
prefLabel
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698